Literature DB >> 24515649

CASPASE-12 and rheumatoid arthritis in African-Americans.

Laura Marshall1, Mohammad Obaidullah, Trista Fuchs, Naomi S Fineberg, Garland Brinkley, Ted R Mikuls, S Louis Bridges, Evan Hermel.   

Abstract

CASPASE-12 (CASP12) has a downregulatory function during infection and thus may protect against inflammatory disease. We investigated the distribution of CASP12 alleles (#rs497116) in African-Americans (AA) with rheumatoid arthritis (RA). CASP12 alleles were genotyped in 953 RA patients and 342 controls. Statistical analyses comparing genotype groups were performed using Kruskal-Wallis non-parametric ANOVA with Mann-Whitney U tests and chi-square tests. There was no significant difference in the overall distribution of CASP12 genotypes within AA with RA, but CASP12 homozygous patients had lower baseline joint-narrowing scores. CASP12 homozygosity appears to be a subtle protective factor for some aspects of RA in AA patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24515649      PMCID: PMC4139147          DOI: 10.1007/s00251-014-0762-9

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  22 in total

1.  Molecular haplotype determination using allele-specific PCR and pyrosequencing technology.

Authors:  Monica Pettersson; Mattias Bylund; Anders Alderborn
Journal:  Genomics       Date:  2003-09       Impact factor: 5.736

Review 2.  Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis.

Authors:  Ernest Choy
Journal:  Rheumatology (Oxford)       Date:  2012-07       Impact factor: 7.580

3.  Genetic associations with RA expanded and strengthened.

Authors:  David Killock
Journal:  Nat Rev Rheumatol       Date:  2012-12-04       Impact factor: 20.543

4.  Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasis.

Authors:  Theo S Plantinga; Omar J M Hamza; Janet A Willment; Bart Ferwerda; Nicole M D van de Geer; Paul E Verweij; Mecky I N Matee; Kathy Banahan; Luke A J O'neill; Bart-Jan Kullberg; Gordon D Brown; André J A M van der Ven; Mihai G Netea
Journal:  J Acquir Immune Defic Syndr       Date:  2010-09       Impact factor: 3.731

5.  Role of NOD1 polymorphism in susceptibility and clinical progression of rheumatoid arthritis.

Authors:  Theo S Plantinga; Jaap Fransen; Rachel Knevel; Mihai G Netea; Jochen Zwerina; Monique M A Helsen; Jos W M van der Meer; Piet L van Riel; Georg Schett; Annette H M van der Helm-van Mil; Wim B van den Berg; Leo A B Joosten
Journal:  Rheumatology (Oxford)       Date:  2013-01-25       Impact factor: 7.580

6.  Expression and function of the NALP3 inflammasome in rheumatoid synovium.

Authors:  Laeticia Kolly; Nathalie Busso; Gaby Palmer; Dominique Talabot-Ayer; Véronique Chobaz; Alexander So
Journal:  Immunology       Date:  2009-08-17       Impact factor: 7.397

7.  Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.

Authors:  Maya Saleh; John P Vaillancourt; Rona K Graham; Matthew Huyck; Srinivasa M Srinivasula; Emad S Alnemri; Martin H Steinberg; Vikki Nolan; Clinton T Baldwin; Richard S Hotchkiss; Timothy G Buchman; Barbara A Zehnbauer; Michael R Hayden; Lindsay A Farrer; Sophie Roy; Donald W Nicholson
Journal:  Nature       Date:  2004-05-06       Impact factor: 49.962

8.  Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis.

Authors:  Lang-Jing Zhu; Lie Dai; Dong-Hui Zheng; Ying-Qian Mo; Xia Ou-Yang; Xiu-Ning Wei; Jun Shen; Bai-Yu Zhang
Journal:  Arthritis Res Ther       Date:  2012-06-04       Impact factor: 5.156

9.  High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

Authors:  Steve Eyre; John Bowes; Dorothée Diogo; Annette Lee; Anne Barton; Paul Martin; Alexandra Zhernakova; Eli Stahl; Sebastien Viatte; Kate McAllister; Christopher I Amos; Leonid Padyukov; Rene E M Toes; Tom W J Huizinga; Cisca Wijmenga; Gosia Trynka; Lude Franke; Harm-Jan Westra; Lars Alfredsson; Xinli Hu; Cynthia Sandor; Paul I W de Bakker; Sonia Davila; Chiea Chuen Khor; Khai Koon Heng; Robert Andrews; Sarah Edkins; Sarah E Hunt; Cordelia Langford; Deborah Symmons; Pat Concannon; Suna Onengut-Gumuscu; Stephen S Rich; Panos Deloukas; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Lisbeth Ärlsetig; Javier Martin; Solbritt Rantapää-Dahlqvist; Robert M Plenge; Soumya Raychaudhuri; Lars Klareskog; Peter K Gregersen; Jane Worthington
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

10.  Caspase-12 and the inflammatory response to Yersinia pestis.

Authors:  Bart Ferwerda; Matthew B B McCall; Maaike C de Vries; Joost Hopman; Boubacar Maiga; Amagana Dolo; Ogobara Doumbo; Modibo Daou; Dirk de Jong; Leo A B Joosten; Rudi A Tissingh; Frans A G Reubsaet; Robert Sauerwein; Jos W M van der Meer; André J A M van der Ven; Mihai G Netea
Journal:  PLoS One       Date:  2009-09-01       Impact factor: 3.240

View more
  3 in total

Review 1.  Converging roles of caspases in inflammasome activation, cell death and innate immunity.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Nat Rev Immunol       Date:  2015-12-14       Impact factor: 53.106

2.  Caspase-12, but Not Caspase-11, Inhibits Obesity and Insulin Resistance.

Authors:  Alexander M Skeldon; Alexandre Morizot; Todd Douglas; Nicola Santoro; Romy Kursawe; Julia Kozlitina; Sonia Caprio; Wajahat Z Mehal; Maya Saleh
Journal:  J Immunol       Date:  2015-11-18       Impact factor: 5.422

3.  Analysis of CASP12 diagnostic and prognostic values in cervical cancer based on TCGA database.

Authors:  Guo Feng; Zhang Beilei; Chen Caizhi; Zou Wen
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.